RCEL
What one share of AVITA Medical holds
Surgical and Medical Instruments and Apparatus
AVITA Medical is a leading therapeutic acute wound care company delivering transformative solutions designed to optimize wound healing, accelerate patient recovery, and improve clinical and economic outcomes across the continuum of acute wound management.
AVITA Medical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.52 |
|---|---|
| Profit | −$1.44 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.82 |
| Cash and investments | $0.36 |
| Debt | $1.39 |
| Book value | −$0.90 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $1.98 | −$1.40 | $0.05 | −$1.56 | — | $1.91 |
| 2024 | $2.48 | −$2.39 | $0.35 | −$2.24 | — | $0.17 |
| 2025 | $2.57 | −$1.74 | $0.04 | −$1.16 | — | −$0.54 |